Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 23 Nov 2016 |
| Bavarian Nordic Completes Enrollment of Phase 3 Non-inferiority Study of IMVAMUNE® Smallpox Vaccine | 23 Nov 2016 |
| Bavarian Nordic Announces Interim Results for the First Nine Months of 2016 | 9 Nov 2016 |
| Bavarian Nordic Announces Initiation of Phase 2 Clinical Trial of RSV Vaccine | 18 Oct 2016 |
| Bavarian Nordic Issues Financial Calendar for 2017 | 13 Sept 2016 |